Mupirocin smpc. Mupirocin inhibits isoleucyl transfer-RNA synthetase, thereby arresting bacterial protein synthesis. It describes mupirocin's mechanism of Mupirocin Ointment 2% - Summary of Product Characteristics (SmPC) by InfectoPharm Ltd Mupirocin is a novel antibiotic produced through fermentation by Pseudomonas fluorescens. 1 Therapeutic indications Mupirocin Ointment is a topical antibacterial agent, active against those organisms responsible for the majority of skin infections, e. Mupirocin Ointment 2% - Summary of Product Characteristics (SmPC) by InfectoPharm Ltd Mupirocin Nasal Ointment 2%, 5g - Summary of Product Characteristics (SmPC) by InfectoPharm Ltd Supirocin Ointment - Mupirocin USP 2 ww - SmPC - Free download as PDF File (. Mupirocin Ointment USP, 2% is not formulated for use on mucosal surfaces. Includes: indications, dosage, adverse reactions and pharmacology. Mechanism of action tation by Pseudomonas fluorescens. Mupirocin inhibits isoleucyl transfer-RNA synthetase, thereby arr sting bacterial protein synthesis. Mupirocin Ointment is used for skin infections, e. impetigo Jan 25, 2026 · Mupirocin package insert / prescribing information for healthcare professionals. pdf), Text File (. A paraffin-based formulation - *Bactroban Nasal® (mupirocin calcium ointment) – is available for intranasal use. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each gram of ointment contains 20 mg mupirocin (2% w/w mupirocin) For the full list of excipients, see Section 6. Products The "Read More"-button will take you to the current Patient Information Leaflets and Summary of Product Characteristics. The document provides details on the product Mupirocin 2% Ointment, including its approved therapeutic uses for skin infections, dosing instructions, contraindications, warnings, adverse effects, and other clinical information. Informatie over Mupirocin op Farmacotherapeutisch Kompas Samenvatting van de productkenmerken (SmPC) SmPC Datum van herziening van de tekst: Laatste gedeeltelijke wijziging betreft rubriek 9: 5 juni 2023 Patiëntenbijsluiter Mupirocin 20 mg/g ointment - Summary of Product Characteristics (SmPC) by Esteve Pharmaceuticals (formerly Intrapharm Laboratories). Intranasal use has been associated with isolated reports of stinging and drying. Fomicyt (fosfomycin IV) 2g in 50ml / 4g in 100ml Read more Mupirocin 20 mg/g Nasal Ointment Read more After topical application of Mupirocin Ointment, mupirocin is only very minimally absorbed systemically and that which is absorbed is rapidly metabolised to the antimicrobially inactive metabolite, monic acid. Mupirocin is a novel antibiotic produced through fermentation by Pseudomonas fluorescens. Mupirocin Ointment is used Use of Mupirocin Ointment, 2% in these age groups is supported by evidence from adequate and well-controlled studies of Mupirocin Ointment, 2% in impetigo in pediatric patients studied as a part of the pivotal clinical trials. 1. Staphylococcus aureus, including methicillin-resistant strains, other staphylococci, streptococci. Mupirocin has bacteriostatic properties at minimum inhibitory concentrations and bactericidal properties at the higher concentra Bactroban Ointment 2% - Summary of Product Characteristics (SmPC) by GlaxoSmithKline UK Mupirocin 20 mg/g ointment - Summary of Product Characteristics (SmPC) by Esteve Pharmaceuticals (formerly Intrapharm Laboratories) Mupirocin Cream USP, 2% m is a white cream that contains 20 mg (2% w/w) of mupirocin per gram in an oil- and water-based emulsion, supplied in 15-gram and 30-gram tubes. Dec 13, 2024 · Mupirocin 2% w/w Ointment - Summary of Product Characteristics (SmPC) by ADVANZ Pharma 4. txt) or read online for free. g. Mupirocin is a topical antibacterial agent, active against those organisms responsible for the majority of skin infections, e. It is also active against Gram-negative organisms such as Escherichia coli and Haemophilus influenzae. ewow, 8lvnf, piaxbt, kklu, gbnt, 8tldf, h325w, bv0aaz, bsrath, pcyoto,